Bitcoin, the largest cryptocurrency by market value, briefly climbed above $78,000 on Binance spot trading, reaching $78,037 on November 2 at 7:14 a.m. ET. This price movement highlights Bitcoin's continued strength and investor interest in the asset. The rise above this threshold is notable as it reflects ongoing momentum in the crypto market, with Bitcoin maintaining a slight gain over the previous hour. Investors will be watching to see if Bitcoin can sustain or build on this level in the near term.
Bitcoin's price briefly reached $78,037 on Binance spot trading on November 2. For readers following cryptocurrency, here is Pluang's market snapshot as of Nov 02, 2026 18:41 WIB: out of 50 major cryptocurrencies priced on Pluang, 5 rose and 44 fell today. Notable movers include EOS with a 1-day change of +8.13% at Rp12.649 and a typical hold time of 87 days, COTI down 6.58% at Rp184 with 89% buy order activity and a 122-day hold time, and BAT down 5.78% at Rp2.394 with 73% sell order activity and a 93-day hold time.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
